| P50 | author | Ali Nokhodchi | Q38318363 |
| | Abdelwahab Omri | Q43604827 |
| | M.r. R. Mozafari | Q74176155 |
| | Abbas Pardakhty | Q80334765 |
| P2093 | author name string | J A Jazayeri | |
| | S Azarmi | |
| P2860 | cites work | Openings between defective endothelial cells explain tumor vessel leakiness | Q24681507 |
| | Nanotechnologies for biomolecular detection and medical diagnostics | Q28292243 |
| | Albumin-bound paclitaxel: a next-generation taxane | Q29027108 |
| | Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review | Q29617388 |
| | Drug delivery systems: entering the mainstream | Q29618136 |
| | Ultrasound mediated delivery of drugs and genes to solid tumors | Q30488681 |
| | Design of dendritic macromolecules containing folate or methotrexate residues | Q30813488 |
| | In vitro release of 5-fluorouracil with cyclic core dendritic polymer | Q31931283 |
| | Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles | Q33244142 |
| | Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer | Q33303505 |
| | Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets | Q33314508 |
| | Targeted drug delivery via the folate receptor | Q33852978 |
| | Targeted delivery of chemotherapeutics: tumor-activated prodrug therapy | Q33933206 |
| | Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. | Q34040103 |
| | Folate-mediated targeting: from diagnostics to drug and gene delivery | Q34133791 |
| | Dendrimers in drug research | Q34291645 |
| | Polyamidoamine cascade polymers mediate efficient transfection of cells in culture | Q34347285 |
| | Nanomedicine: current status and future prospects. | Q34399915 |
| | Caelyx: phase II studies in ovarian cancer | Q34462134 |
| | Paclitaxel and its formulations | Q34552648 |
| | Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro. | Q34592802 |
| | Nanotechnology applications in cancer | Q34619838 |
| | Microscopical investigations of nisin-loaded nanoliposomes prepared by Mozafari method and their bacterial targeting | Q34661463 |
| | Dendritic polymer macromolecular carriers for drug delivery | Q34754647 |
| | Pegylated liposomal doxorubicin (Doxil) for metastatic breast cancer: the Cancer Research Network, Inc., experience | Q35004475 |
| | Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications | Q35111358 |
| | The dawning era of polymer therapeutics | Q35128900 |
| | Targeting cancer cells by exploiting their resistance | Q35192546 |
| | Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects. | Q35204546 |
| | Nanotech approaches to drug delivery and imaging | Q35609123 |
| | Folate-targeted chemotherapy | Q35749880 |
| | Nanoparticle and targeted systems for cancer therapy | Q35879221 |
| | Dendrimers and dendritic polymers in drug delivery | Q36022312 |
| | Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. | Q36062352 |
| | Targeted drug delivery in cancer therapy | Q36200150 |
| | Dendrimers in biomedical applications--reflections on the field | Q36321345 |
| | Dendrimers in gene delivery | Q36323319 |
| | Supramolecular structures from dendrons and dendrimers | Q36323804 |
| | Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment | Q36477445 |
| | Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicability. | Q36501883 |
| | Influence of tumour size on uptake of(111)ln-DTPA-labelled pegylated liposomes in a human tumour xenograft model | Q36621814 |
| | Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes | Q36713632 |
| | The present and future of nanotechnology in human health care | Q36767174 |
| | pH-sensitive liposomes--principle and application in cancer therapy | Q36790100 |
| | Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles | Q36833069 |
| | The role of high-resolution imaging in the evaluation of nanosystems for bioactive encapsulation and targeted nanotherapy | Q36899352 |
| | Recent advances in basic and clinical nanomedicine. | Q36934312 |
| | Nanomedicine and drug delivery | Q36934321 |
| | Polymeric micelles for drug targeting | Q36985038 |
| | Antibody-targeted liposomes in cancer therapy and imaging | Q37076367 |
| | Nanotechnology in vaccine delivery | Q37104199 |
| | Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin | Q40025224 |
| | Targeting to tumor necrotic regions with biotinylated antibody and streptavidin modified liposomes | Q40049622 |
| | Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome | Q40104855 |
| | Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy | Q40107579 |
| | In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicin | Q40343380 |
| | Preparation and characterization of liposomes as therapeutic delivery systems: a review | Q40469440 |
| | Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy | Q40491524 |
| | Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study | Q40550975 |
| | Synthesis of starlike N-(2-hydroxypropyl)methacrylamide copolymers: potential drug carriers | Q40768440 |
| | Cross-linked guar gum microspheres: a viable approach for improved delivery of anticancer drugs for the treatment of colorectal cancer. | Q41854833 |
| | In vitro gene delivery to hepatocytes with galactosylated polyethylenimine | Q42833898 |
| | Nutrient uptake by protocells: a liposome model system. | Q43570847 |
| | Phase II study of pegylated liposomal doxorubicin (Caelyx) as induction chemotherapy for patients with squamous cell cancer of the head and neck | Q43764068 |
| | Tumor regression by targeted gene delivery to the neovasculature | Q44044889 |
| | Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor | Q44196277 |
| | A PEGylated dendritic nanoparticulate carrier of fluorouracil | Q44414029 |
| | Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs | Q44528275 |
| | Nanoparticle drug delivery system for intravenous delivery of topoisomerase inhibitors | Q44558783 |
| | PEG-Ara-C conjugates for controlled release | Q44778882 |
| | Liposomal doxorubicin-induced toxicity: depletion and impairment of phagocytic activity of liver macrophages | Q44945836 |
| | A novel liposomal bupivacaine formulation to produce ultralong-acting analgesia | Q44954332 |
| | Anticancer drug delivery systems: multi-loaded N4-acyl poly(ethylene glycol) prodrugs of ara-C. II. Efficacy in ascites and solid tumors | Q45712667 |
| | Polymeric nanoparticles as delivery system for influenza virus glycoproteins | Q45753775 |
| | Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier | Q46591212 |
| | Polyalkylcyanoacrylate nanoparticles as carriers for granulocyte-colony stimulating factor (G-CSF). | Q47758729 |
| | Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses. | Q47829371 |
| | Global non-viral gene transfer to the primate brain following intravenous administration | Q48393623 |
| | Liposomal doxorubicin and weekly paclitaxel in the treatment of metastatic breast cancer | Q49133381 |
| | Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin. | Q50467668 |
| | Nanomedicine--prospective therapeutic and diagnostic applications. | Q51540815 |
| | Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma. | Q55473881 |
| | A New Class of Polymers: Starburst-Dendritic Macromolecules | Q56486016 |
| | Preparation of liposomes by reverse-phase evaporation using alternative organic solvents | Q57084462 |
| | Non-ionic surfactant based vesicles (niosomes) in drug delivery | Q57610510 |
| | The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery | Q58622784 |
| | Dendrimers: a new class of nanoscopic containers and delivery devices | Q58737668 |
| P433 | issue | 4 | |
| P921 | main subject | nanocarrier | Q17153796 |
| P304 | page(s) | 310-321 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Journal of Liposome Research | Q6295453 |
| P1476 | title | Role of nanocarrier systems in cancer nanotherapy | |
| P478 | volume | 19 | |